Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 0 | 0 | 0 | 115 | 81 |
Cost of Goods | N/A | N/A | N/A | 40 | 36 |
Gross Profit | N/A | N/A | N/A | 75 | 45 |
Operating Expenses | 4,474 | 3,567 | 3,145 | 2,415 | 2,045 |
Operating Income | -4,474 | -3,567 | -3,145 | -2,300 | -1,964 |
Interest Expense | 0 | 0 | 0 | 2,003 | 1,256 |
Other Income | 696 | 4,548 | 27 | -1,343 | 0 |
Pre-tax Income | -3,778 | 981 | -3,118 | -5,646 | -3,220 |
Net Income Continuous | -3,778 | 981 | -3,118 | -5,646 | -3,220 |
Net Income | $-3,778 | $981 | $-3,118 | $-5,646 | $-3,220 |
EPS Basic Total Ops | -0.54 | 0.18 | -0.72 | -0.90 | -1.56 |
EPS Basic Continuous Ops | -0.51 | 0.18 | -0.72 | -0.85 | -1.54 |
EPS Diluted Total Ops | -0.54 | 0.18 | -0.72 | -0.90 | -1.56 |
EPS Diluted Continuous Ops | -0.51 | 0.18 | -0.72 | -0.85 | -1.54 |
EBITDA(a) | $-4,474 | $-3,567 | $-3,145 | $-2,299 | $-1,964 |